ZNTL
NASDAQ
US
Zentalis Pharmaceuticals, Inc. - common stock
$2.63
▲ +$0.06
(+2.33%)
Vol 358K
2
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$97.5M
ROE
-51.3%
D/E
0.00
Beta
1.74
52W
$1–$3
Wall Street Consensus
15 analysts · Apr 20264
Strong Buy
5
Buy
6
Hold
0
Sell
0
Strong Sell
60.0%
Buy Rating
Price Chart
Similar Stocks
KRRO
Korro Bio Inc
$75.4M
NVCT
Nuvectis Pharma Inc
$193.4M
ANIK
Anika Therapeutics Inc
$138.6M
SABS
SAB Biotherapeutics Inc
P/E 9.5
$178.0M
ELTX
Elicio Therapeutics Inc
$139.2M
MGNX
MacroGenics Inc
$101.8M
CRBU
Caribou Biosciences Inc
$148.6M
TNXP
Tonix Pharmaceuticals Holding Corp
$199.7M
CRBP
Corbus Pharmaceuticals Holdings Inc
$142.9M
Earnings
Beat rate: 100.0%
Next Report
May 12, 2026
EPS Estimate: $-0.50
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.50 | — | — |
| Dec 2025 | $-0.59 | $-0.50 | +$0.09 |
| Sep 2025 | $-0.54 | $-0.37 | +$0.17 |
| Jun 2025 | $-0.59 | $-0.37 | +$0.22 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -51.4% | -51.6% | -51.6% | -51.6% | -51.3% | -51.3% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 7.99 | 7.99 | 7.99 | 7.99 | 7.76 | 7.76 |
Key Ratios
ROA (TTM)
-39.9%
P/B
0.6
EPS (TTM)
$-2.08
CF/Share
$-3.33
52W High
$3.33
52W Low
$1.01
$1.01
52-Week Range
$3.33
How does ZNTL compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
ZNTL valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
0.6
▼
74%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
ZNTL profitability vs Biotechnology peers
ROE
-51.3%
▲
24%
above
peers
(-67.3%)
vs Peers
vs Industry
Below avg
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-39.9%
▲
15%
above
peers
(-46.7%)
vs Peers
vs Industry
In line
ZNTL financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
7.8
▲
75%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
1.7
▲
80%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
ZNTL fundamentals radar
ZNTL
Peer median
Industry
ZNTL profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
ZNTL vs peers: key metrics
Latest News
No related news yet